Consult the medical resource doctors trust

UpToDate is one of the most respected medical information resources in the world, used by over 360,000 doctors and thousands of patients to find answers to medical questions.

  • Content written by a faculty of over 4,000 physicians from leading medical institutions
  • Unbiased: free of advertising or pharmaceutical funding
  • Evidence-based treatment recommendations
  • Continuously updated to incorporate new medical findings

Diffuse esophageal spasm and nutcracker esophagus

INTRODUCTION

The clinical relevance of esophageal motility abnormalities such as diffuse esophageal spasm (DES) and the nutcracker esophagus is best understood when working from a classification system for these abnormalities. Prior to discussing the current classification system, it is helpful to first briefly review the history and controversy surrounding attempts to understand the pathophysiology of these disorders.

An esophageal motility disorder (EMD) is defined as motility that differs significantly from accepted normal variations. In the early years of esophageal motility testing, these "disorders" were primarily descriptions of motility findings in patients with otherwise unexplained symptoms, usually dysphagia or chest pain. As an example, William Osler first described esophageal spasms in 1892 in hypochondriacal patients with unexplained chest pain [1]. The older radiology literature also used terms such as "presbyesophagus," reflecting abnormal peristalsis that was thought to be age-related [2]. This term should not be seriously considered since there is scant evidence that any esophageal dysmotility occurs as a direct result of aging. More recently, classifications of esophageal motility abnormalities have been based more specifically upon motility findings that exceeded two standard deviations from those found in a large group of normal subjects [3].

There is considerable controversy concerning the clinical significance of abnormal esophageal motility patterns. The most important questions are whether they represent actual disorders or are only manometric abnormalities and whether they cause or explain the patient's symptoms. With the exception of achalasia, no specific pathology or pathophysiology has been described for any of these dysmotility patterns, including the more generally accepted "disorder" of DES.

This topic review will attempt to characterize the relevant information on these motility abnormalities without the implication that they are actual disease entities, excluding the one true motility disorder, achalasia. (See "Clinical manifestations and diagnosis of achalasia".) An overview of chest pain of esophageal origin is discussed separately. (See "Chest pain of esophageal origin".)

CLASSIFICATION OF ESOPHAGEAL MOTILITY ABNORMALITIES

Esophageal motility abnormalities are generally classified into those that are an isolated phenomenon (primary) (table 1) and those associated with generalized disease (secondary) (table 2). Within each of these major categories, the motility abnormalities can usually be subcategorized into hypercontracting, hypocontracting, and discoordinated motility.

To continue reading this article you need to subscribe.

Read the rest of this article and others like it

The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use (click here) ©2010 UpToDate, Inc.
References Top
  1. Osler, W. Principles and practice of medicine. D Appleton and Co, New York, NY 1892. p.329.
  2. DeVault, KR. Presbyesophagus: a reappraisal. Curr Gastroenterol Rep 2002; 4:193.
  3. Richter, JE, Wu, WC, Johns, DN, et al. Esophageal manometry in 95 healthy adult volunteers: Variability of pressures with age and frequency of "abnormal" contractions. Dig Dis Sci 1987; 32:583.
  4. Creamer, B, Donoghue, E, Code, CF. Pattern of esophageal motility in diffuse spasm. Gastroenterology 1958; 34:782.
  5. Richter, JE, Castell, DO. Diffuse esophageal spasm: A reappraisal. Ann Intern Med 1984; 100:242.
  6. Dalton, CB, Castell, DO, Hewson, EG, et al. Diffuse esophageal spasm. A rare motility disorder not characterized by high amplitude contractions. Dig Dis Sci 1991; 36:1025.
  7. Sperandio, M, Tutuian, R, Gideon, RM, et al. Diffuse esophageal spasm: not diffuse but distal esophageal spasm (DES). Dig Dis Sci 2003; 48:1380.
  8. Allen, ML, Di Marino, AJ Jr. Manometric diagnosis of diffuse esophageal spasm. Dig Dis Sci 1996; 41:1346.
  9. Tutuian, R, Mainie, I, Agrawal, A, et al. Symptom and function heterogenicity among patients with distal esophageal spasm. Am J Gastroenterol 2006; 101:464.
  10. DiMarino, AJ Jr. Characteristics of lower esophageal sphincter function in symptomatic diffuse esophageal spasm. Gastroenterology 1974; 66:1.
  11. Miller, LS, Parkman, HP, Schiano, TD, et al. Treatment of symptomatic nonachalasia esophageal motor disorders with botulinum toxin injection at the lower esophageal sphincter. Dig Dis Sci 1996; 41:2025.
  12. Campo, S, Traube, M. Lower esophageal sphincter dysfunction in diffuse esophageal spasm. Am J Gastroenterol 1989; 84:928.
  13. Konturek, JW, Gillessen, A, Domschke, W. Diffuse esophageal spasm: A malfunction that involves nitric oxide? Scand J Gastroenterol 1995; 30:1041.
  14. Orlando, RC, Bozymski, EM. Clinical and manometric effects of nitroglycerin in diffuse esophageal spasm. N Engl J Med 1973; 289:23.
  15. Swamy, N. Esophageal spasm: Clinical and manometric response to nitroglycerine and long acting nitrates. Gastroenterology 1977; 72:23.
  16. Brand, D, Martin, D, Pope, CE 2d. Esophageal manometrics in patients with angina-like chest pain. Am J Dig Dis 1977; 22:300.
  17. Benjamin, SB, Gerhardt, DC, Castell, DO. High amplitude peristaltic esophageal contractions associated with chest pain and/or dysphagia. Gastroenterology 1979; 77:478.
  18. Castell, DO. The nutcracker esophagus, the hypertensive lower esophageal sphincter, and nonspecific esophageal motility disorders. In: Esophageal Motility Testing, D Castell, J Castell (Ed), Appleton & Lange, Norwalk, CT 1994. p.135.
  19. Eypasch, E, Stein, H, De Meester, T, et al. A new technique to define and clarify esophageal motor disorders. Am J Surg 1990; 159:144.
  20. Jung, HY, Puckett, JL, Bhalla, V, et al. Asynchrony between the circular and the longitudinal muscle contraction in patients with nutcracker esophagus. Gastroenterology 2005; 128:1179.
  21. Korsapati, H, Bhargava, V, Mittal, RK. Reversal of asynchrony between circular and longitudinal muscle contraction in nutcracker esophagus by atropine. Gastroenterology 2008; 135:796.
  22. Katz, PO, Dalton, CB, Richter, JE, et al. Esophageal testing of patients with noncardiac chest pain or dysphagia. Ann Intern Med 1987; 106:593.
  23. Mujica, VR, Mudipalli, RS, Rao, SS. Pathophysiology of chest pain in patients with nutcracker esophagus. Am J Gastroenterol 2001; 96:1371.
  24. Agrawal, A, Hila, A, Tutuian, R, et al. Clinical relevance of the nutcracker esophagus: suggested revision of criteria for diagnosis. J Clin Gastroenterol 2006; 40:504.
  25. CODE, CF, SCHLEGEL, JF, KELLEY, ML Jr, et al. Hypertensive gastroesophageal sphincter. Mayo Clin Proc 1960; 35:391.
  26. Freidin, N, Traube, M, Mittal, R, et al. The hypertensive lower esophageal sphincter. Dig Dis Sci 1989; 34:1066.
  27. Waterman, DC, Dalton, CB, Ott, DJ, et al. Hypertensive lower esophageal sphincter: What does it mean? J Clin Gastroenterol 1989; 11:139.
  28. Cattau, EL, Castell, DO, Johnson, DA, et al. Diltiazem therapy for symptoms associated with nutcracker esophagus. Am J Gastroenterol 1991; 86:272.
  29. Clouse, RE, Lustman, PJ, Eckert, TC, et al. Low dose trazodone for symptomatic patients with esophageal contraction abnormalities: A double-blind, placebo controlled trial. Gastroenterology 1987; 92:1027.
  30. Cannon, RO, Quyyumi, AA, Mincemoyer, R, et al. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med 1994; 330:1411.
  31. Stein, HJ, DeMeester, TR. Therapy of noncardiac chest pain: Is there a role for surgery?. Am J Med 1992; 92:122S.
  32. Storr, M, Allescher, HD, Rosch, T, et al. Treatment of symptomatic diffuse esophageal spasm by endoscopic injections of botulinum toxin: A prospective study with long-term follow-up. Gastrointest Endosc 2001; 54:754.
  33. Miller, LS, Pullela, SV, Parkman, HP, et al. Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal. Am J Gastroenterol 2002; 97:1640.
  34. Triadafilopoulos, G, Tsang, HP, Segall, GM. Hot water swallows improve symptoms and accelerate esophageal clearance in esophageal motility disorders. J Clin Gastroenterol 1998; 26:239.
  35. Pimentel, M, Bonorris, GG, Chow, EJ, Lin, HC. Peppermint oil improves the manometric findings in diffuse esophageal spasm. J Clin Gastroenterol 2001; 33:27.
  36. Eherer, AJ, Schwetz, I, Hammer, HF, et al. Effect of sildenafil on oesophageal motor function in healthy subjects and patients with oesophageal motor disorders. Gut 2002; 50:758.
  37. Agrawal, A, Tutuian, R, Hila, A, Castell, D. Successful use of phosphodiesterase type 5 inhibitors to control symptomatic esophageal hypercontractility. Dig Dis Sci 2005; 50:2059.
  38. Agrawal, A, Hila, A, Tutuian, R, et al. Bethanechol improves smooth muscle function in patients with severe ineffective esophageal motility. J Clin Gastroenterol 2007; 41:366.
white circle LOG IN
white circle DEMO